Icnmdigital Speaker Disclosures 09.02.2020NG.Xlsx

Name Individual's Role(s) Name of Commercial Interest(s) Nature of Relationship(s) Scientific Session in Activity Abati, Elena Speaker Nothing to disclose Nothing to disclose Scientific Session 06 Alvarez Velasco, Rodrigo Speaker Nothing to disclose Nothing to disclose Scientific Session 09 Beeson, David Speaker 1) Programme Grant, Medical Research Council, UK 1) Receipt of grants/research supports Scientific Session 07 Benaviste, Olivier Speaker Nothing to disclose Nothing to disclose Scientific Session 01 Callaghan, Brian Speaker 1) NIDDK R01, VA Merit CSR&D, JDRF, AAN 1) Receipt of grants/research supports Scientific Session 05 2) Neurology editorial board 2) Reciept of honoraia or consultation fees 3) Dynamed consultant, medicolegal consultation including the 3) Other Vaccine Injury Compensation Program Chelban, Viorica Speaker Nothing to disclose Nothing to disclose Scientific Session 06 Djordjevic, Djurdja Speaker Nothing to disclose Nothing to disclose Scientific Session 06 Evoli, Amelia Speaker 1) UCB 1) Receipt of honoraria or consultation fees (member data monitoring Scientific Session 08 2) Grifols committee) 2) Receipt of Honararia or consulataion fees (Research award jury member) Exposito Escudero, Jesica Maria Speaker Nothing to disclose Nothing to disclose Scientific Session 12 Finkel, Richard Speaker 1) Avexis, Biogen, Capricor, Catebasis, Reveragen, Roche, 1) Receipt of grants/research supports Scientific Session 11 Scholar Rock 2) Reciept of honoraia or consultation fees 2) Avexis, Biogen, Caterasis, Roch, Neurogene 3) Spouse/partner 3) Licencing fees from patents: National Jewish Center, 4) Other support Children's Hospital of Philadelphia 4) Licensing fees rom Children's Hospital of Philadelphia, Royalty payments from Elseview Flanigan, Kevin Speaker 1) Sarepta Therapeutics, Audentes Therapeutic 1) Receipt of grants/research supports Scientific Session 01 2) 4D Molecular Therapeutics, Apic Bio 2) Reciept of honoraia or consultation fees Gilhus, Nils Erik Speaker 1) RaPharma, UCB, Argenx, Alexion, Octapharma 1) Reciept of honoraia or consultation fees Scientific Session 08 Howard, James Speaker 1) Alexion Pharmaceuticals, argenx BVBA, the Centers for 1) Receipt of grants/research supports Scientific Session 09 Disease Control and Prevention (Atlanta, GA, USA), the Muscular 2) Reciept of honoraia or consultation fees Dystrophy Association, the National Institutes of Health 3) Stock Shareholder (including the National Institute of Neurological Disorders and 4) Spouse/partner Stroke and the National Institute of Arthritis and 5) Other ‐ non financial support Musculoskeletal and Skin Diseases), Ra Pharmaceuticals 2) Alexion Pharmaceuticals, argenx BVBA, Ra Pharmaceuticals and Viela Bio Inc. 3) Johnson & Johnson, Pfizer 4) GSK 5) Alexion Pharmaceuticals, argenx BVBA, Ra Pharmaceuticals and Toleranzia Name Individual's Role(s) Name of Commercial Interest(s) Nature of Relationship(s) Scientific Session in Activity Laporte, Jocelyn Speaker Nothing to disclose Nothing to disclose Scientific Session 03 Lauria, Giuseppe Speaker Nothing to disclose Nothing to disclose Scientific Session 04 Llamusi, Beatriz Speaker Nothing to disclose Nothing to disclose Scientific Session 03 Querol, Luis Speaker 1) Fondo Investigaciones Sanitarias, Grifols, Roche, CIBERER 1) Receipt of grants/research supports Scientific Session 04 2) Grifols, Roche, Sanofi, Merck, Novatis, CSU, Alexion, Annexon, 2) Reciept of honoraia or consultation fees Johnson & Johnson 3) Participation in a company sponsored speaker's bureau 3) CSL Behring, Roche, Novaris, UCB, Merck

Reilly, Mary Speaker 1) Ad hoc consultancy fees Alnylam, Akcea, Inflectis 1) Reciept of honoraia or consultation fees Scientific Session 05 Reyes Garrido, Virginia Speaker Nothing to disclose Nothing to disclose Scientific Session 12 Scaglioni, Dominic Speaker 1) Sarepta Therapeutics 1) Receipt of grants/research supports Scientific Session 03 Servais, Laurent Speaker 1) Roche, Avexis, Biogen 1) Receipt of grants/research supports Scientific Session 11 2) Roche, Avexis, Biogen, Cytokinetics 2) Reciept of honoraia or consultation fees Straub, Volker Speaker Nothing to disclose Nothing to disclose Scientific Session 02 Tannemaat, Martijn Speaker 1) Trial support from Argen‐X and Alexion (all reimbursements 1) Receipt of grants/research supports Scientific Session 09 received by the LUMC) Traynor, Bryan Speaker 1) Merck Inc & Microsoft Research 1) Receipt of grants/research supports Scientific Session 10 2) Other 2)Patent on the diagnostic use of C9orf72, support from The Myasthenia Gravis Foundation, the ALS foundation, CDC, the intramural research program of the NIH. Dr. Traynor is on the editorial board of JNNP, Neurobiology of Aging, and Jama Neurology. Van Den Berg , Leonard Speaker 1) U‐trail Utrecht 1) Receipt of grants/research supports Scientific Session 10 2) UCM Utrecht 2) Reciept of honoraia or consultation fees Vissing, John Speaker 1) UCB Pharma, Edgewise Therapeutics, Sanofi/Genzyme, 1) Received research and travel support, and/or speaker honararia Scientific Session 02 Fulcrum Therapeutics, Alexion Pharmaceuticals, Genethon

Wolfe, Gil Speaker 1) NIDS/NCATS of the National Institutes of Health, MG 1) Receipt of grants/research supports Scientific Session 07 Foundation of America, Muscular Dystrophy Association